1. Home
  2. ASRV vs GBIO Comparison

ASRV vs GBIO Comparison

Compare ASRV & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRV
  • GBIO
  • Stock Information
  • Founded
  • ASRV 1983
  • GBIO 2016
  • Country
  • ASRV United States
  • GBIO United States
  • Employees
  • ASRV N/A
  • GBIO N/A
  • Industry
  • ASRV Major Banks
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASRV Finance
  • GBIO Health Care
  • Exchange
  • ASRV Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • ASRV 48.4M
  • GBIO 41.2M
  • IPO Year
  • ASRV N/A
  • GBIO 2020
  • Fundamental
  • Price
  • ASRV $3.05
  • GBIO $5.51
  • Analyst Decision
  • ASRV
  • GBIO Buy
  • Analyst Count
  • ASRV 0
  • GBIO 4
  • Target Price
  • ASRV N/A
  • GBIO $10.67
  • AVG Volume (30 Days)
  • ASRV 37.0K
  • GBIO 49.6K
  • Earning Date
  • ASRV 10-21-2025
  • GBIO 11-07-2025
  • Dividend Yield
  • ASRV 3.93%
  • GBIO N/A
  • EPS Growth
  • ASRV N/A
  • GBIO N/A
  • EPS
  • ASRV 0.30
  • GBIO N/A
  • Revenue
  • ASRV $53,488,000.00
  • GBIO $21,230,000.00
  • Revenue This Year
  • ASRV N/A
  • GBIO N/A
  • Revenue Next Year
  • ASRV N/A
  • GBIO N/A
  • P/E Ratio
  • ASRV $10.17
  • GBIO N/A
  • Revenue Growth
  • ASRV 17.45
  • GBIO 61.15
  • 52 Week Low
  • ASRV $2.03
  • GBIO $3.00
  • 52 Week High
  • ASRV $3.42
  • GBIO $25.70
  • Technical
  • Relative Strength Index (RSI)
  • ASRV 49.76
  • GBIO 36.99
  • Support Level
  • ASRV $3.01
  • GBIO $5.36
  • Resistance Level
  • ASRV $3.19
  • GBIO $6.47
  • Average True Range (ATR)
  • ASRV 0.20
  • GBIO 0.29
  • MACD
  • ASRV -0.00
  • GBIO -0.13
  • Stochastic Oscillator
  • ASRV 39.58
  • GBIO 9.62

About ASRV AmeriServ Financial Inc.

AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: